Getting Imaging Right: Multimodal Assessment of Right-Sided Heart Function in Patients Undergoing Tricuspid Repair
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
Associations of Self-Reported Race, Social Determinants of Health, and Polygenic Risk With Coronary Heart Disease
Social determinants of health (SDOH) influence the risk of common diseases such as coronary heart disease (CHD).
Answering the Call: Enhancing Telemedicine Reach With Artificial intelligence Integration
Considering Social and Genetic Factors in Cardiovascular Disease Risk
5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
The Amulet IDE trial (AMPLATZER Amulet Left Atrial Appendage Occluder [LAAO] Investigational Device Exemption [IDE] Trial) evaluated the safety and effectiveness of the Amulet occluder (Abbott) in patients with nonvalvular atrial fibrillation. The Amulet IDE trial is the largest randomized LAAO trial, comparing the Amulet occluder with the Watchman 2.5 device (Boston Scientific).
Reply: Answering the Call: Enhancing Telemedicine Reach With Artificial intelligence Integration
Anatomic and Physiologic Repair of Congenitally Corrected Transposition of the Great Arteries
Congenitally corrected transposition of the great arteries (ccTGA) is a rare cardiac anomaly. The management strategy historically consisted of physiologic repair, leaving the morphologic right ventricle to support the systemic circulation. More recently, anatomic repair has been implemented to bring the left ventricle into the systemic circulation. Uncertainty persists about which repair strategy has the best outcome.
Reply: Revealing the Hidden Layers: Focus on Social and Psychological Determinants in Congenital Heart Surgery Prognosis
Clinical Signs of Congestion in Younger Patients With Decompensated Heart Failure
Reply: Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus
Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a fatal disease, caused by misfolded transthyretin depositing as amyloid fibrils in the heart. Because disease progression is common, practical and sensitive methods are needed to monitor patients and optimize treatment decisions. Outpatient worsening heart failure (HF) (oral loop diuretic intensification or initiation) is simple to assess and has been shown to be prognostic of mortality in patients with ATTR-CM.
Adding AI to the Toolkit for Patients With Implantable Cardioverter-Defibrillators
Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure
Mineralocorticoid receptor antagonists (MRA) improve outcomes in patients with heart failure and reduced ejection fraction (HFrEF) but are underused in clinical practice. Observational data suggest that hyperkalemia is the leading obstacle for the suboptimal use of MRA.
Revealing the Hidden Layers: Focus on Social and Psychological Determinants in Congenital Heart Surgery Prognosis
Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators
Predicting the clinical trajectory of individual patients with implantable cardioverter-defibrillators (ICDs) is essential to inform clinical care. Machine learning approaches can potentially overcome the limitations of conventional statistical methods and provide more accurate, personalized risk estimates.
Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy
The impact of tricuspid regurgitation (TR) on cardiac remodeling has not been thoroughly studied in a randomized controlled trial using advanced imaging.
Congenitally Corrected Transposition of the Great Arteries: The Impact of Anatomic vs Physiologic Repair
Worsening Heart Failure: An Opportunity for Treatment Implementation Even With a Preserved Ejection Fraction?
